You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

~ Buy the COMBIVENT RESPIMAT (albuterol sulfate; ipratropium bromide) Drug Profile, 2024 PDF Report in the Report Store ~

COMBIVENT RESPIMAT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Combivent Respimat, and what generic alternatives are available?

Combivent Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. There are six patents protecting this drug and one Paragraph IV challenge.

This drug has one hundred and eighteen patent family members in thirty-six countries.

The generic ingredient in COMBIVENT RESPIMAT is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.

Drug patent expirations by year for COMBIVENT RESPIMAT
Drug Prices for COMBIVENT RESPIMAT

See drug prices for COMBIVENT RESPIMAT

Paragraph IV (Patent) Challenges for COMBIVENT RESPIMAT
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
COMBIVENT RESPIMAT Inhalation Aerosol albuterol sulfate; ipratropium bromide 100 mcg/20 mcg per actuation 021747 1 2023-03-30

US Patents and Regulatory Information for COMBIVENT RESPIMAT

COMBIVENT RESPIMAT is protected by six US patents.

Patents protecting COMBIVENT RESPIMAT

Piston-pumping system having o-ring seal properties
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Blocking device for a locking stressing mechanism having a spring-actuated output drive device
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Device for clamping a fluidic component
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Microstructured high pressure nozzle with built-in filter function
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Atomizer and method of atomizing fluid with a nozzle rinsing mechanism
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Device for clamping a fluidic component
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim COMBIVENT RESPIMAT albuterol sulfate; ipratropium bromide SPRAY, METERED;INHALATION 021747-001 Oct 7, 2011 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Boehringer Ingelheim COMBIVENT RESPIMAT albuterol sulfate; ipratropium bromide SPRAY, METERED;INHALATION 021747-001 Oct 7, 2011 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Boehringer Ingelheim COMBIVENT RESPIMAT albuterol sulfate; ipratropium bromide SPRAY, METERED;INHALATION 021747-001 Oct 7, 2011 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Boehringer Ingelheim COMBIVENT RESPIMAT albuterol sulfate; ipratropium bromide SPRAY, METERED;INHALATION 021747-001 Oct 7, 2011 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Boehringer Ingelheim COMBIVENT RESPIMAT albuterol sulfate; ipratropium bromide SPRAY, METERED;INHALATION 021747-001 Oct 7, 2011 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Boehringer Ingelheim COMBIVENT RESPIMAT albuterol sulfate; ipratropium bromide SPRAY, METERED;INHALATION 021747-001 Oct 7, 2011 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for COMBIVENT RESPIMAT

International Patents for COMBIVENT RESPIMAT

See the table below for patents covering COMBIVENT RESPIMAT around the world.

Country Patent Number Title Estimated Expiration
Norway 20060412 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 2007128381 ⤷  Try a Trial
Turkey 9801032 ⤷  Try a Trial
Estonia 04773 Mikrostruktureeritud filter vedelike jaoks ja seda filtrit sisaldav pihusti inhalatsiooniteraapiaks ⤷  Try a Trial
Taiwan 446574 ⤷  Try a Trial
Canada 2233981 DISPOSITIF DESTINE A CONTENIR UN FLUIDE (DEVICE FOR HOLDING A FLUIDIC COMPONENT) ⤷  Try a Trial
Yugoslavia 49111 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.